Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer

British Journal of Cancer

Volumn 93, Issue 10, 2005, Pages 1128-1136

  Van Den Eynden, G G ^a,b   Van Der Auwera, I ^a,b   Van Laere, S J ^a,b   Colpaert, C G ^a,b   Turley, H ^c   Harris, A L ^d   Van Dam, P ^a,b   Dirix, L Y ^a,b   Vermeulen, P B ^a,b,e   Van Marck, E A ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b SINT AUGUSTINUS HOSPITAL   (Belgium)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e NONE   (Belgium)

Author keywords

Angiogenesis; Breast cancer; Hypoxia; Lymph node metastasis

Indexed keywords

BIOLOGICAL MARKER; CARBONATE DEHYDRATASE IX; CD34 ANTIGEN; DIFFERENTIATED EMBRYO CHONDROCYTE PROTEIN 1; ENZYME; EOSIN; HEMATOXYLIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER GROWTH; CELL FRACTIONATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL HYPOXIA; CELL PROLIFERATION; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC;

EID: 27944465354     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602828     Document Type: Article

References (58)

1. Aranda F, Laforga J (1996) Microvessel quantitation in breast ductal invasive carcinoma. Correlation with proliferative activity, hormonal receptors and lymph node metastases. Pathol Res Pract 192: 124-129
2. Arapandoni-Dadioti P, Giatromanolaki A, Trihia H, Harris AL, Koukourakis M (1999) Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis. Cancer Lett 137: 145-150
3. Blackwell K, Dewhirst M, Liotcheva V, Snyder S, Broadwater G, Bentley R, Lal A, Riggins G, Anderson S, Vredenburgh J, Proia A, Harris LN (2004) HER-2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors. Clin Cancer Res 10: 4083-4088
4. Bloom H, Richardson W (1957) Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377
5. Bos R, Van Der Groep P, Greijer A, Shvarts A, Meijer S, Pinedo H, Semenza GL, Van Diest PJ, Van Der Wall E (2003) Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97: 1573-1581
6. Bos R, Van Diest PJ, De Jong JS, Van Der Groep P, Van Der Valk P, Van Der Wall E (2005) Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46: 31-36
7. Bos R, Zhong H, Hanrahan C, Mommers E, Semenza GL, Pinedo H, Abeloff MD, Simons J, Van Diest PJ, Van Der Wall E (2001) Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93: 309-314
8. Carmeliet P, Dor Y, Herbert J, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch C, Ratcliffe P, Moons L, Jain R, Collen D, Keshert E (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490
9. Chakrabarti J, Turley H, Campo L, Han C, Harris A, Gatter K, Fox S (2004) The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer 91: 954-958
10. Chang J, Clark GM, Allred D, Mohsin S, Chamness G, Elledge R (2003) Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 97: 545-553
11. Chau N, Rogers P, Aherne W, Carroll V, Collins I, Mcdonald E, Workman P, Ashcroft M (2005) Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Res 65: 4918-4928
12. Chia S, Wykoff C, Watson PH, Han C, Leek R, Pastorek J, Gatter KC, Ratcliffe P, Harris AL (2001) Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19: 3660-3668
13. Colpaert C, Vermeulen P, Fox S, Harris AL, Dirix L, Van Marck EA (2003a) The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Res Treat 81: 137-147
14. Colpaert C, Vermeulen P, Van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E (2001) Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients. Histopathology 39: 416-425
15. Colpaert C, Vermeulen P, Van Beest P, Soubry A, Goovaerts G, Dirix L, Harris A, Van Marck EA (2003b) Cutaneous breast cancer deposits show distinct growth patterns with different degrees of angiogenesis, hypoxia and fibrin deposition. Histopathology 42: 530-540
16. Costello P, Mccann A, Carney DN, Dervan P (1995) Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 26: 1181-1184
17. Currie M, Hanrahan V, Gunningham S, Morrin HR, Frampton C, Han C, Robinson B, Fox S (2004) Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. J Clin Pathol 57: 829-834
18. Dery M, Michaud MD, Richard D (2005) Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37: 535-540
19. Donegan W (1992) Prognostic factors. Stage and receptor status in breast cancer. Cancer 70: 1755-1764
20. Edel M, Harvey J, Papadimitriou J (2000) Comparison of vascularity and angiogenesis in primary invasive mammary carcinomas and in their respective axillary lymph node metastases. Clin Exp Metastasis 18: 695-702
21. Elston CW (1987) Grading of invasive carcinoma of the breast. In Diagnostic Histopathology of the Breast, In Page DL, Anderson TJ (eds) p 300-311. New York: Churchill Livingstone
22. Folkman J (1986) How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res 46: 467-473
23. Forsythe J, Jiang B, Iyer N, Agani F, Leung SW, Koos R, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613
24. Fox S, Leek R, Smith K, Hollyer J, Greenall M, Harris A (1994) Tumor angiogenesis in node-negative breast carcinomas - relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 29: 109-116
25. Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P, Gatti C, Suzuki H, Tominaga T (1997) Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 89: 139-147
26. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F (1994) Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466
27. Giatromanolaki A, Koukourakis M, Simopoulos C, Polychronidis A, Gatter K, Harris AL, Sivridis E (2004) c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent. Clin Cancer Res 10: 7972-7977
28. Giatromanolaki A, Koukourakis M, Sivridis E, Turley H, Wykoff CC, Gatter K, Harris AL (2003) DEC1 (STRA13) protein expression relates to hypoxia-inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol 200: 222-228
29. Green F, Balch C, Fleming ID, Fritz A, Haller D, Morrow M, Page D (2002) Title: AJCC Cancer Staging Handbook: 6/e TNM Classification of Malignant Tumors, vol. 140. New York: Springer-Verlag
30. Gruber G, Greiner R, Hlushchuk R, Aebersold D, Altermatt H, Berclaz G, Djonov V (2004) Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res 6: R191-R198
31. Guidi A, Berry DA, Broadwater G, Perloff M, Norton L, Barcos M, Hayes DF (2000) Association of angiogenesis in lymph node metastases with outcome of breast cancer. J Natl Cancer Inst 92: 486-492
32. Hansen S, Grabau D, Sorensen F, Bak M, Vach W, Rose C (2000) The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6: 139-146
33. Harris AL (2002) Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47
34. Hasebe T, Tsuda H, Hirohashi S, Shimosato Y, Tsubono Y, Yamamoto H, Mukai K (1998) Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res Treat 49: 195-208
35. Heimann R, Hellman S (2000) Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol 18: 591-599
36. Horak E, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124
37. Jiang B, Agani F, Passaniti A, Semenza G (1997) V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57: 5328-5335
38. Joyce JA (2005) Therapeutic targeting of the tumor microenvironment. Cancer Cell 7: 513-520
39. Kerbel R (1990) Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 55: 87-132
40. Koukourakis M, Manolas C, Minopoulos G, Giatromanolaki A, Sivridis E (2003) Angiogenesis relates to estrogen receptor negativity, c-erbB-2 overexpression and early relapse in node-negative ductal carcinoma of the breast. Int J Surg Pathol 11: 29-34
41. Linderholm B, Grankvist K, Wilking N, Johansson M, Tavelin B, Henriksson R (2000) Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. J Clin Oncol 18: 1423-1431
42. Maxwell P, Dachs G, Gleadle J, Nicholls L, Harris A, Stratford I, Hankinson O, Pugh C, Ratcliffe P (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94: 8104-8109
43. Monsky W, Mouta Carreira C, Tsuzuki Y, Gohongi T, Fukumura D, Jain R (2002) Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res 8: 1008-1013
44. Nathanson S (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98: 413-423
45. Pantel K, Brakenhoff R (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-456
46. Schindl M, Schoppmann S, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G (2002) Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8: 1831-1837
47. Semenza GL (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578
48. Stessels F, Van Den Eynden G, Van Der Auwera I, Salgado R, Van Den Heuvel E, Harris A, Jackson D, Colpaert C, Van Marck EA, Dirix L, Vermeulen P (2004) Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer 90: 1429-1436
49. Subramaniam D, Isaacs C (2005) Utilizing prognostic and predictive factors in breast cancer. Curr Treat Options Oncol 6: 147-159
50. Tan C, De Noronha RG, Roecker A, Pyrzynska B, Khwaja F, Zhang Z, Zhang H, Teng Q, Nicholson A, Giannakakou P, Zhou W, Olson J, Pereira M, Nicolaou K, Van Meir EG (2005) Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res 65: 605-612
51. Uzzan B, Nicolas P, Cucherat M, Perret G (2004) Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64: 2941-2955
52. Vartanian R, Weidner N (1994) Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 144: 1188-1194
53. Vaupel P (2004) The role of hypoxia-induced factors in tumor progression. Oncologist 9(Suppl 5): 10-17
54. Vermeulen P, Gasparini G, Fox S, Colpaert C, Marson LP, Gion M, Belien J, De Waal RM, Van Marck E, Magnani E, Weidner N, Harris A, Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38: 1564-1579
55. Vermeulen P, Gasparini G, Fox S, Toi M, Martin L, Mcculloch P, Pezzella F, Viale G, Weidner N, Harris A, Dirix L (1996) Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474-2484
56. Vleugel M, Greijer A, Shvarts A, Van Der Groep P, Van Berkel M, Aarbodem Y, Van Tinteren H, Harris A, Van Diest PJ, Van Der Wall E (2005) Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 58: 172-177
57. Weidner N, Semple J, Welch W, Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
58. Wykoff C, Pugh C, Maxwell PH, Harris A, Ratcliffe P (2000) Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 19: 6297-6305